title: Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH: reply.
authors: Department of Haematology, Manchester Royal Infirmary, Manchester, UK.
authors: J
authors: J
authors: Thachil
authors: Department of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy.
authors: A
authors: A
authors: Falanga
authors: Faculty of Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
authors: M
authors: M
authors: Levi
authors: Division of Hematology, USC Norris Cancer Hospital, Los Angeles, CA, USA.
authors: H
authors: H
authors: Liebman
authors: Department of Medical, Oral and Biotechnological Sciences, University 'G. D'Annunzio' of Chieti-Pescara, Chieti, Italy.|Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands.
authors: M
authors: M
authors: Di Nisio
mesh_terms: D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects*; D001803:Blood Transfusion / Q000592:standards*; D004211:Disseminated Intravascular Coagulation / Q000628:therapy*; D006801:Humans; D009369:Neoplasms / Q000150:complications*
chemical_list: D000933:Antifibrinolytic Agents